Among these, 14-3-3ε—implicated in tumor invasiveness and metastasis—and PDCD6IP/ALIX—a key regulator of EGFR activity and immune checkpoint trafficking—were also validated by Western blot analysis. Here, PDCD6IP is linked to neoplasm.